Imatinib mesylate associated with delayed hematopoietic recovery after concomitant chemotherapy. [electronic resource]
Producer: 20040503Description: 886-7; author reply 887-8 p. digitalISSN:- 0887-6924
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Benzamides
- Hematopoiesis -- drug effects
- Humans
- Imatinib Mesylate
- Leukemia, Myeloid, Chronic-Phase -- drug therapy
- Lymphoma, B-Cell -- drug therapy
- Lymphoma, Follicular
- Male
- Neoplasms, Second Primary -- drug therapy
- Piperazines -- adverse effects
- Pyrimidines -- adverse effects
No physical items for this record
Publication Type: Case Reports; Comment; Letter
There are no comments on this title.
Log in to your account to post a comment.